Curaleaf Launches Plant Precision, New Merchandise Line Targeting Unique Wellbeing and Wellness Classes

Plant Precision fills shopper need for low dose THC formats that are geared in direction of day-to-day wellness as 75% of Individuals would take into account working with hashish for wellness and wellness functions*

WAKEFIELD, Mass., July 25, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA /OTCQX: CURLF) (“Curaleaf” or the “Business”), a primary global supplier of buyer goods in hashish, right now announced the start of Plant Precision, a curated assortment of edibles and a topical gel created to focus on specific wellness classes.

According to a Curaleaf / Harris Poll study, 69% of Americans say they would be much more probable to use cannabis as a health and fitness option if it came in tiny, controlled doses*. Curaleaf recognized this want and developed an approachable line for the more recent wellness-oriented buyer featuring gummy edibles featuring small, customizable doses of THC and superior doses of non-psychoactive therapeutic insignificant cannabinoids like CBD, CBG, CBN and THCV, and a swiftly absorbent THC topical gel.

Plant Precision will allow buyers to examine a range of likely therapeutic destinations these as:

• Balance: an apple-flavored gummy made up of 2.5mg THC and 10mg CBD for waking up, winding down, or providing a second of relaxed
• Slumber: a cherry-flavored gummy that contains 2.5mg THC and 10mg CBN which could be a beneficial addition to a nighttime regime to help fall (and stay) asleep
• Soothe: a pineapple-flavored gummy made up of 2.5mg THC and 10mg CBG for rebounding soon after travel, lengthy routines, or prolonged weekends
• Strengthen: a lemon-flavored gummy that contains 2.5mg THC and 10mg THCV for starting your working day with a minimal more excitement
• Reduce: a substantial absorbing topical gel with 100% THC designed to fast relieve tension with a 30–45-moment onset time

The minimal cannabinoids featured in Plant Precision gummies are non-psychoactive and do not build the euphoric feeling like THC does, but as an alternative interact in different ways with the human receptor units yielding unique organic results. The Plant Precision gummies utilize liposomal encapsulation, a technology which envelopes the cannabinoid molecules, to assistance optimize each milligram. Furthermore, each and every of the Plant Precision Gummy lines include formulated blends of terpenes that add to the entourage effect, which takes place when minimal cannabinoids interact with THC to develop a exceptional outcome with probable therapeutic rewards.

The Plant Precision Topical Gel was engineered applying hydro-alcoholic technology to aid the shipping of cannabinoids by the pores and skin and has 650mg of whole THC** – increased than just about all marketed THC topicals.

“With Plant Precision we required to generate a simplified way individuals can integrate cannabis into their everyday overall health and wellness routines,” explained Matt Darin, CEO of Curaleaf. “These merchandise empower people to investigate hashish further than THC and CBD and presents a lot more customizable options on how the plant can ideal provide a consumer’s individualized requires.”

Plant Precision merchandise will in the beginning start at Curaleaf locations in 5 states now as a result of August. The gummies*** and gel are out there in Arizona and Massachusetts, with the gel also readily available in Florida, Nevada and Utah. For extra details on solution availability, you should check out https://curaleaf.com/plant-precision.

These statements have not been evaluated by the Food and Drug Administration (Fda). These goods are not intended to diagnose, deal with, remedy, or avoid any sickness. Maintain out of reach of small children. Customers really should seek advice from with their physician right before utilizing this product or service if they are pregnant, breastfeeding, or are getting any medications.

Trader Contact
Curaleaf Holdings, Inc.
Trader Relations
[email protected]

MEDIA Get in touch with
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
[email protected]

About Curaleaf Holdings
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a foremost intercontinental service provider of shopper products and solutions in cannabis with a mission to enhance life by delivering clarity all around hashish and self-assurance around usage. As a high-growth hashish company known for high-quality, expertise and reliability, the Company and its makes, like Curaleaf and Choose, offer market-major services, product or service variety and accessibility across the professional medical and grownup-use markets. In the United States, Curaleaf at this time operates in 22 states with 134 dispensaries, 26 cultivation websites, and employs around 5,700 crew users. Curaleaf Worldwide is the biggest vertically integrated cannabis organization in Europe with a special offer and distribution network during the European marketplace, bringing alongside one another groundbreaking science and study with reducing-edge cultivation, extraction and generation. Curaleaf is outlined on the Canadian Securities Exchange below the symbol CURA and trades on the OTCQX market place below the symbol CURLF. For a lot more info, be sure to visit https://ir.curaleaf.com.

Ahead Searching Statements
This media advisory has forward–looking statements and forward–looking info inside of the indicating of applicable securities legal guidelines. These statements relate to potential occasions or potential overall performance. All statements other than statements of historic truth might be forward–looking statements or facts. Typically, forward-looking statements and data could be discovered by the use of forward-wanting terminology these as “options”, “expects” or, “proposed”, “is expected”, “intends”, “anticipates”, or “believes”, or variants of these kinds of phrases and phrases, or by the use of phrases or phrases which point out that selected actions, situations or effects may perhaps, could, would, or could arise or be realized. More particularly and without having limitation, this information release has forward–looking statements and information and facts relating to the launch of new Plant Precision solutions. This kind of forward-seeking statements and data replicate management’s recent beliefs and are centered on assumptions created by and information and facts at the moment out there to the organization with regard to the matter described in this new release. Ahead-wanting statements contain hazards and uncertainties, which are based on present-day expectations as of the day of this launch and subject matter to recognized and unfamiliar hazards and uncertainties that could cause real final results to vary materially from these expressed or implied by these types of statements. Supplemental details about these assumptions and risks and uncertainties is contained below “Possibility Aspects and Uncertainties” in the Firm’s newest once-a-year information type filed March 9, 2022, which is readily available below the Firm’s SEDAR profile at http://www.sedar.com, and in other filings that the Organization has produced and may well make with applicable securities authorities in the foreseeable future. Forward-hunting statements contained herein are designed only as to the date of this push launch and we undertake no obligation to update or revise any forward-on the lookout statements whether or not as a result of new details, long term occasions or if not, apart from as needed by law. We warning investors not to area substantial reliance on the forward hunting statements contained in this push release. The Canadian Securities Trade has not reviewed, approved or disapproved the articles of this information release.

*Study Technique:
This survey was performed online within the United States by The Harris Poll on behalf of Curaleaf from March 8-10, 2022, among 1,953 grown ups ages 21+, amid whom 1,095 have hardly ever applied cannabis. The sampling precision of Harris on the net polls is calculated by making use of a Bayesian credible interval.  For this review, the sample facts is precise to inside of + 2.8 share factors making use of a 95% confidence amount. For finish study methodology, like weighting variables and subgroup sample dimensions, remember to call [email protected].

** Topical THC stages are 650mg except in a point out where by polices have highest THC guidelines, like MA

***Entire variety of gummy availability dependent on the regulatory position of minimal cannabinoids (CBD, CBG, CBN, THCV) by state

Resource Curaleaf Holdings, Inc.